MCID: RCT008
MIFTS: 42

Rectosigmoid Junction Neoplasm

Categories: Cancer diseases, Cardiovascular diseases, Gastrointestinal diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Rectosigmoid Junction Neoplasm

MalaCards integrated aliases for Rectosigmoid Junction Neoplasm:

Name: Rectosigmoid Junction Neoplasm 11 14
Neoplasm of Rectosigmoid Junction 11 71
Rectosigmoid Neoplasm 11 75
Primary Malignant Neoplasm of Rectosigmoid Junction 33
Malignant Tumor of Rectosigmoid Junction 71
Carcinoma of the Rectosigmoid Junction 71
Carcinoma of Rectum with Sigmoid 33
Rectosigmoid Junction Cancer 33
Rectosigmoid Colon Cancer 33
Colorectal Carcinoma Nos 33
Rectosigmoid Carcinoma 71
Colorectal Cancer Nos 33
Rectosigmoid Cancer 33
Rectosigmoid Tumor 11

Classifications:



External Ids:

Disease Ontology 11 DOID:2780
NCIt 49 C4877
SNOMED-CT 68 126848003
UMLS 71 C0153443 C0345873 C0559004 more

Summaries for Rectosigmoid Junction Neoplasm

MalaCards based summary: Rectosigmoid Junction Neoplasm, also known as neoplasm of rectosigmoid junction, is related to rectosigmoid cancer and rectum cancer. An important gene associated with Rectosigmoid Junction Neoplasm is GTF2H5 (General Transcription Factor IIH Subunit 5). The drugs Capecitabine and Antimetabolites have been mentioned in the context of this disorder. Affiliated tissues include colon, lymph node and liver, and related phenotype is neoplasm.

Wikipedia: 75 Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development... more...

Related Diseases for Rectosigmoid Junction Neoplasm

Diseases related to Rectosigmoid Junction Neoplasm via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 340)
# Related Disease Score Top Affiliating Genes
1 rectosigmoid cancer 32.2 MLH1 KRAS CEACAM5
2 rectum cancer 30.3 MLH1 KRT20 KRAS CEACAM5
3 anal fistula 29.9 KRT7 KRT20
4 intrahepatic cholangiocarcinoma 29.7 KRT7 KRAS CEACAM5
5 obstructive jaundice 29.7 KRT7 CEACAM5
6 colon adenocarcinoma 29.3 MLH1 KRT20 KRAS CEACAM5
7 intestinal obstruction 29.1 KRT7 KRT20 CEACAM5 CDX2
8 anus disease 29.1 KRT7 KRAS CEACAM5 CDX2
9 appendix adenocarcinoma 28.8 KRT7 KRT20 KRAS CEACAM5 CDX2
10 cholangiocarcinoma 28.8 KRT7 KRT20 KRAS CEACAM5 CDX2
11 adenocarcinoma 28.6 MLH1 KRT7 KRT20 KRAS CEACAM5 CDX2
12 rectal benign neoplasm 28.3 MLH1 KRT7 KRT20 KRAS CEACAM5 CDX2
13 mucinous adenocarcinoma 28.3 MLH1 KRT7 KRT20 KRAS CEACAM5 CDX2
14 colorectal adenocarcinoma 28.3 MLH1 KRT7 KRT20 KRAS CEACAM5 CDX2
15 colonic benign neoplasm 28.3 MLH1 KRT7 KRT20 KRAS CEACAM5 CDX2
16 colorectal cancer 10.6
17 eccrine papillary adenoma 10.2 KRT20 CEACAM5
18 signet ring basal cell carcinoma 10.2 KRAS CEACAM5
19 immature teratoma of ovary 10.2 KRAS CEACAM5
20 ovarian cystadenoma 10.2 KRT7 CEACAM5
21 pancreatic cystadenocarcinoma 10.2 KRAS CEACAM5
22 hepatic flexure cancer 10.2 KRAS CEACAM5
23 apocrine adenocarcinoma 10.2 KRT7 CEACAM5
24 pancreatic mucinous cystadenoma 10.2 KRAS CEACAM5
25 syringoma 10.2 KRT7 CEACAM5
26 leukoplakia of penis 10.2 KRT7 CEACAM5
27 aggressive digital papillary adenocarcinoma 10.2 KRT7 CEACAM5
28 cutaneous mucoepidermoid carcinoma 10.2 KRT7 CEACAM5
29 malignant epithelial mesothelioma 10.2 KRT7 CEACAM5
30 malignant spiradenoma 10.2 KRT7 CEACAM5
31 spiradenoma 10.2 KRT7 CEACAM5
32 adenosquamous bile duct carcinoma 10.2 KRT7 CEACAM5
33 ureter squamous cell carcinoma 10.2 KRT7 CEACAM5
34 apocrine adenoma 10.2 KRT7 CEACAM5
35 vulval paget's disease 10.2 KRT7 CEACAM5
36 renal pelvis adenocarcinoma 10.2 KRT7 CEACAM5
37 malignant biphasic mesothelioma 10.2 KRT7 CEACAM5
38 adenoid basal cell carcinoma 10.2 KRT7 CEACAM5
39 nodular hidradenoma 10.2 KRT7 CEACAM5
40 hidradenoma 10.2 KRT7 CEACAM5
41 malignant acrospiroma 10.2 KRT7 CEACAM5
42 eccrine adenocarcinoma 10.2 KRT7 CEACAM5
43 bile duct mucoepidermoid carcinoma 10.2 KRT7 CEACAM5
44 male urethral cancer 10.2 KRT7 KRT20
45 clear cell hidradenoma 10.1 KRT7 CEACAM5
46 pericardial mesothelioma 10.1 KRT7 CEACAM5
47 pancreatoblastoma 10.1 KRAS CEACAM5
48 squamous cell bile duct carcinoma 10.1 KRT7 CEACAM5
49 adenoid squamous cell carcinoma 10.1 KRT7 CEACAM5
50 pericardium cancer 10.1 KRT7 CEACAM5

Comorbidity relations with Rectosigmoid Junction Neoplasm via Phenotypic Disease Network (PDN): (show all 15)


Active Peptic Ulcer Disease Acute Cystitis
Ascending Colon Cancer Cecal Benign Neoplasm
Colorectal Cancer Deficiency Anemia
Descending Colon Cancer Hepatic Flexure Cancer
Hydronephrosis Intestinal Obstruction
Intestinal Perforation Iron Deficiency Anemia
Paralytic Ileus Protein-Energy Malnutrition
Transverse Colon Cancer

Graphical network of the top 20 diseases related to Rectosigmoid Junction Neoplasm:



Diseases related to Rectosigmoid Junction Neoplasm

Symptoms & Phenotypes for Rectosigmoid Junction Neoplasm

MGI Mouse Phenotypes related to Rectosigmoid Junction Neoplasm:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 9.02 CDX2 CEACAM5 KRAS MLH1 SMUG1

Drugs & Therapeutics for Rectosigmoid Junction Neoplasm

Drugs for Rectosigmoid Junction Neoplasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 17)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Capecitabine Approved, Investigational Phase 4 154361-50-9 60953
2 Antimetabolites Phase 4
3 Cola Phase 4
4
Aflibercept Approved Phase 2 862111-32-8 124490314
5
Levoleucovorin Approved, Experimental, Investigational Phase 2 68538-85-2, 58-05-9, 73951-54-9 149436 6006
6
Fluorouracil Approved Phase 2 51-21-8 3385
7
Oxaliplatin Approved, Investigational Phase 2 61825-94-3 43805 11947679 6857599
8
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
9 Vitamins Phase 2
10 Folate Phase 2
11 Vitamin B9 Phase 2
12 Trace Elements Phase 2
13 Angiogenesis Inhibitors Phase 2
14 Vitamin B Complex Phase 2
15 Antidotes Phase 2
16 Micronutrients Phase 2
17 Protective Agents Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 An Open Label, Phase II Study of Capecitabine (Xeloda) Plus Conformal Radiotherapy for Patients With Locally Advanced, Non-Metastatic Rectosigmoid Carcinoma Terminated NCT00216424 Phase 4 Capecitabine (Xeloda)
2 A Randomized Trial of the Altering Intake, Managing Symptoms Intervention for Bowel Dysfunction in Rectal Cancer Survivors Compared to a Healthy Living Education Control: A Feasibility and Preliminary Efficacy Study (AIMS-RC) Active, not recruiting NCT04205955 Phase 2
3 mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer: a Randomized Phase-II-trial Active, not recruiting NCT03043729 Phase 2 Oxaliplatin;5-FU;Leucovorin
4 Role of CD133 and Microsatellite Status in Evaluation of Young Adults With Rectosigmoid Cancer Received Neoadjuvant Treatment Unknown status NCT03002727
5 A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry Recruiting NCT05566249
6 Circulating Tumor Elements in Patients With Rectal Cancer Recruiting NCT02874885
7 Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials Recruiting NCT05108298 Early Phase 1
8 Comparison of Rectosigmoid Resection and Seromuscular Tumor Shaving Methods in Ovarian Cancer Surgery (BROSEOC) Recruiting NCT04665635
9 Pilot Study of a Personalized Dietary Intervention to Manage Bowel Dysfunction in Rectal Cancer Survivors Active, not recruiting NCT03063918
10 A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection Terminated NCT02205307

Search NIH Clinical Center for Rectosigmoid Junction Neoplasm

Genetic Tests for Rectosigmoid Junction Neoplasm

Anatomical Context for Rectosigmoid Junction Neoplasm

Organs/tissues related to Rectosigmoid Junction Neoplasm:

MalaCards : Colon, Lymph Node, Liver, Prostate, Small Intestine, Kidney, Uterus

Publications for Rectosigmoid Junction Neoplasm

Articles related to Rectosigmoid Junction Neoplasm:

(show top 50) (show all 346)
# Title Authors PMID Year
1
Robotic resection for obstructed rectosigmoid colon cancer with clinically suspicious para-aortic lymph node metastasis and direct invasion into the uterus - A video vignette. 62
35596924 2022
2
D3 lymph node dissection with versus without left colic artery preservation in single-incision laparoscopic surgery for sigmoid and rectosigmoid cancer: A propensity score-matched analysis. 62
36443942 2022
3
Endoscopy Reports for Rectosigmoid Tumors: Frequently Missing Key Information Needed for Surgical Planning. 62
35659707 2022
4
Mechanical bowel preparation with or without oral antibiotics for rectal resection for cancer (REPCA trial): a study protocol for a multicenter randomized controlled trial. 62
36151343 2022
5
Colorectal Cancer Risk Is Impacted by Sex and Type of Surgery After Bariatric Surgery. 62
35731459 2022
6
Rectosigmoid Cancer-Rectal Cancer or Sigmoid Cancer? 62
35848736 2022
7
Gastric Volvulus: Diagnosis and Successful Endoscopic De-rotation Towards Conservative Management in a Patient With Multiple Comorbidities. 62
35854951 2022
8
Modification of ALPPS to avoid ischemia and congestion after stage 1: a case report. 62
35867313 2022
9
Laparoscopic anterior resection for patients with rectosigmoid cancer in situs inversus totalis - a video vignette. 62
35068038 2022
10
Robotic versus laparoscopic anterior resections for rectal and rectosigmoid cancer: an institutional experience. 62
33846946 2022
11
Distance of Peritoneum to Inferior Mesenteric Artery Predicts the Operation Time During Laparoscopic Colectomy for Sigmoid or Rectosigmoid Colon Cancer. 62
35399172 2022
12
Efficacy of side-to-end anastomosis to prevent anastomotic leakage after anterior resection for rectal cancer. 62
35003742 2022
13
National trends in hospitalizations among patients with colorectal cancer in the United States. 62
35261440 2022
14
Risk factors and economic burden of postoperative anastomotic leakage related events in patients who underwent surgeries for colorectal cancer. 62
35584082 2022
15
Laparoscopic surgery using 8 K ultra-high-definition technology: Outcomes of a phase II study. 62
33881224 2022
16
A six years' experience with 41 cases of enterovesical fistula in a Tertiary National Hospital in Indonesia: A retrospective study. 62
35028134 2022
17
[The Validity of a Stent-Independent Strategy for Left-Sided Stenotic Colon Cancer]. 62
35046303 2021
18
ANALGESIC EFFECT OF VARIOUS RADIOPHARMACEUTICALS IN THE COMPLEX TREATMENT OF METASTATIC BONE DISEASE. 62
34965574 2021
19
A new spray-type adhesion barrier (AdSpray) improves condition for surgical treatment in the reversal of Hartmann procedure: A case report. 62
35049209 2021
20
[A Case of Laparoscopic Resection for Rectal Cancer with Persistent Descending Mesocolon]. 62
35045499 2021
21
Correlation between ASA Grade with reversal of Hartmann's procedure - a retrospective study. 62
35126744 2021
22
Necrotizing fasciitis of the lower extremity secondary to a perforated rectosigmoid tumor. 62
34975101 2021
23
Rising incidence of colorectal cancer in individuals younger than 50 years and increasing mortality from rectosigmoid cancer in England. 62
34310037 2021
24
Clinical effect and standardization of indocyanine green angiography in the laparoscopic colorectal surgery. 62
35600102 2021
25
Metachronous common iliac lymph node metastasis after rectosigmoid colon cancer resection: A case report. 62
34280878 2021
26
Single-incision versus conventional multiport laparoscopic surgery for colorectal cancer: a meta-analysis of randomized controlled trials and propensity-score matched studies. 62
33829313 2021
27
Changes in colorectal cancer incidence by site and age from 1973 to 2015: a SEER database analysis. 62
33025301 2021
28
Long-term outcome of indwelling colon observed seven years after radical resection for rectosigmoid cancer: A case report. 62
34307575 2021
29
Short-term clinical and oncological outcomes after single-incision plus one-port laparoscopic surgery for rectosigmoid cancer: a retrospective clinical analysis of 30 cases. 62
34250822 2021
30
Robotic low anterior resection with total hysterectomy, bilateral salpingo-oophorectomy and en bloc pelvic peritonectomy followed by hyperthermic intraperitoneal chemotherapy for the multi-modal treatment of rectosigmoid cancer with peritoneal seeding - A video vignette. 62
33675572 2021
31
Implantation of rectosigmoid cancer in a preexisting anal fissure. 62
33786288 2021
32
Comprehensive analysis of lncRNA-associated ceRNA network reveals the novel potential of lncRNA, miRNA and mRNA biomarkers in human rectosigmoid junction cancer. 62
33552263 2021
33
Safe Completion of Laparoscopic Anterior Resection in a Patient With a Solitary Pelvic Kidney: A Case Report. 62
33730797 2021
34
Pelvic local recurrence as first relapse predicts prognosis for clinical stage II/III lower rectal cancer: A clinicopathological investigation. 62
33414914 2021
35
Does the Endoscopic Surgical Skill Qualification System improve patients' outcome following laparoscopic surgery for colon cancer? A multicentre, retrospective analysis with propensity score matching. 62
33608034 2021
36
Competing Endogenous RNA in Colorectal Cancer: An Analysis for Colon, Rectum, and Rectosigmoid Junction. 62
34178670 2021
37
RNA-Associated Co-expression Network Identifies Novel Biomarkers for Digestive System Cancer. 62
33841514 2021
38
A Postsurgical Prognostic Nomogram for Locally Advanced Rectosigmoid Cancer to Assist in Patient Selection for Adjuvant Chemotherapy. 62
35004292 2021
39
Is early anvil placement an alternative technique to reduce anastomotic leak after rectosigmoid cancer resection? 62
33576338 2021
40
Laparoscopic Surgery for Colorectal Cancer in Super-Elderly Patients: A Single-Center Analysis. 62
33234850 2020
41
Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank. 62
32830201 2020
42
Three-trocar tubeless natural orifice specimen extraction surgery in rectosigmoid cancer - a video vignette. 62
32336013 2020
43
Laparoscopic vs. Open Surgery for Stage II/III Colon Cancer Patients With Body Mass Index >25 kg/m2. 62
32606186 2020
44
Colorectal Intussusception Due to Rectosigmoid Junction Cancer: A Unique Surgical Challenge? 62
31713812 2020
45
Robotic multivisceral resection for a locally advanced rectosigmoid cancer - a video vignette. 62
31965699 2020
46
The effect of primary tumor radiotherapy in patients with Unresectable stage IV Rectal or Rectosigmoid Cancer: a propensity score matching analysis for survival. 62
32460810 2020
47
Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-2015. 62
32235162 2020
48
Low rate of local recurrence detection by rectoscopy in follow-up of rectal cancer. 62
31556190 2020
49
Feasibility of needlescopic surgery for colorectal cancer: safety and learning curve for Japanese Endoscopic Surgical Skill Qualification System-unqualified young surgeons. 62
31087171 2020
50
Covid-19 mimicking symptoms in emergency gastrointestinal surgery cases during pandemic: A case series. 62
33137666 2020

Variations for Rectosigmoid Junction Neoplasm

Cosmic variations for Rectosigmoid Junction Neoplasm:

8 (show all 44)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM112254813 TP53 large intestine,rectum,other,ulcerative colitis c.991C>T p.Q331* 17:7673537-7673537 4
2 COSM144087932 TP53 large intestine,rectum,other,ulcerative colitis c.514C>T p.Q172* 17:7673537-7673537 4
3 COSM144014702 TP53 large intestine,rectum,other,ulcerative colitis c.958C>T p.Q320* 17:7673537-7673537 4
4 COSM122735329 TP53 large intestine,rectum,other,ulcerative colitis c.595C>T p.Q199* 17:7673537-7673537 4
5 COSM142561421 TP53 large intestine,rectum,other,ulcerative colitis c.874C>T p.Q292* 17:7673537-7673537 4
6 COSM143372079 TP53 large intestine,rectum,other,ulcerative colitis c.874C>T p.Q292* 17:7673537-7673537 4
7 COSM144311322 TP53 large intestine,rectum,other,ulcerative colitis c.874C>T p.Q292* 17:7673537-7673537 4
8 COSM87899785 TP53 large intestine,rectum,other,ulcerative colitis c.991C>T p.Q331* 17:7673537-7673537 4
9 COSM122272916 TP53 large intestine,rectum,other,ulcerative colitis c.595C>T p.Q199* 17:7673537-7673537 4
10 COSM143945088 TP53 large intestine,rectum,other,ulcerative colitis c.514C>T p.Q172* 17:7673537-7673537 4
11 COSM143158051 TP53 large intestine,rectum,other,ulcerative colitis c.514C>T p.Q172* 17:7673537-7673537 4
12 COSM93184982 TP53 large intestine,rectum,other,ulcerative colitis c.991C>T p.Q331* 17:7673537-7673537 4
13 COSM121877930 TP53 large intestine,rectum,other,ulcerative colitis c.595C>T p.Q199* 17:7673537-7673537 4
14 COSM105621819 TP53 large intestine,rectum,other,ulcerative colitis c.782+644C>T p.? 17:7673537-7673537 4
15 COSM144652581 TP53 large intestine,rectum,other,ulcerative colitis c.874C>T p.Q292* 17:7673537-7673537 4
16 COSM145019112 TP53 large intestine,rectum,other,ulcerative colitis c.874C>T p.Q292* 17:7673537-7673537 4
17 COSM111759749 TP53 large intestine,rectum,other,ulcerative colitis c.991C>T p.Q331* 17:7673537-7673537 4
18 COSM106054584 TP53 large intestine,rectum,other,ulcerative colitis c.991C>T p.Q331* 17:7673537-7673537 4
19 COSM142838247 TP53 large intestine,rectum,other,ulcerative colitis c.991C>T p.Q331* 17:7673537-7673537 4
20 COSM103099638 SMAD4 large intestine,rectum,other,ulcerative colitis c.1546C>T p.Q516* 18:51078354-51078354 4
21 COSM139783160 SMAD4 large intestine,rectum,other,ulcerative colitis c.1258C>T p.Q420* 18:51078354-51078354 4
22 COSM91397295 SMAD4 large intestine,rectum,other,ulcerative colitis c.1546C>T p.Q516* 18:51078354-51078354 4
23 COSM87804055 KRAS large intestine,colon,other,ulcerative colitis c.35G>T p.G12V 12:25245350-25245350 4
24 COSM87804005 KRAS large intestine,colon,other,ulcerative colitis c.35G>A p.G12D 12:25245350-25245350 4
25 COSM134990112 KRAS large intestine,colon,other,ulcerative colitis c.35G>A p.G12D 12:25245350-25245350 4
26 COSM134990158 KRAS large intestine,colon,other,ulcerative colitis c.35G>T p.G12V 12:25245350-25245350 4
27 COSM134990131 KRAS large intestine,colon,other,ulcerative colitis c.38G>A p.G13D 12:25245347-25245347 4
28 COSM134615012 KRAS large intestine,colon,other,ulcerative colitis c.34G>T p.G12C 12:25245351-25245351 4
29 COSM134614922 KRAS large intestine,colon,other,ulcerative colitis c.35G>A p.G12D 12:25245350-25245350 4
30 COSM91859716 KRAS large intestine,colon,other,ulcerative colitis c.35G>A p.G12D 12:25245350-25245350 4
31 COSM87811077 KRAS large intestine,colon,other,ulcerative colitis c.37G>A p.G13S 12:25245348-25245348 4
32 COSM134990190 KRAS large intestine,colon,other,ulcerative colitis c.34G>T p.G12C 12:25245351-25245351 4
33 COSM134614978 KRAS large intestine,colon,other,ulcerative colitis c.35G>T p.G12V 12:25245350-25245350 4
34 COSM134995752 KRAS large intestine,colon,other,ulcerative colitis c.37G>A p.G13S 12:25245348-25245348 4
35 COSM91859771 KRAS large intestine,colon,other,ulcerative colitis c.34G>T p.G12C 12:25245351-25245351 4
36 COSM87804028 KRAS large intestine,colon,other,ulcerative colitis c.38G>A p.G13D 12:25245347-25245347 4
37 COSM91865142 KRAS large intestine,colon,other,ulcerative colitis c.37G>A p.G13S 12:25245348-25245348 4
38 COSM91859752 KRAS large intestine,colon,other,ulcerative colitis c.35G>T p.G12V 12:25245350-25245350 4
39 COSM134614942 KRAS large intestine,colon,other,ulcerative colitis c.38G>A p.G13D 12:25245347-25245347 4
40 COSM134622234 KRAS large intestine,colon,other,ulcerative colitis c.37G>A p.G13S 12:25245348-25245348 4
41 COSM91859734 KRAS large intestine,colon,other,ulcerative colitis c.38G>A p.G13D 12:25245347-25245347 4
42 COSM87804075 KRAS large intestine,colon,other,ulcerative colitis c.34G>T p.G12C 12:25245351-25245351 4
43 COSM122380143 APC large intestine,colon,other,Crohn disease c.3386T>C p.L1129S 5:112838980-112838980 3
44 COSM88864376 APC large intestine,colon,other,Crohn disease c.3386T>C p.L1129S 5:112838980-112838980 3

Expression for Rectosigmoid Junction Neoplasm

Search GEO for disease gene expression data for Rectosigmoid Junction Neoplasm.

Pathways for Rectosigmoid Junction Neoplasm

GO Terms for Rectosigmoid Junction Neoplasm

Sources for Rectosigmoid Junction Neoplasm

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....